MIDECAMYCIN;antibioticsf837;antibioticsf837a1;antibioticyl704b1;espinomycina;leucomycinv,3,4(supb)-dipropanoate;medemycin;midecamycina(sub1);LEUCOMYCIN V 3,4(B)-DIPROPIONATE;Mydecamycin;Antibiotic SF-837;SF-837
Cas No.
35457-80-8
分子式
C41H67NO15
分子量
813.97
包装储存
Powder; -20°C; 3 years; 4°C; 2 years;
生物活性
Midecamycin, an acetoxy-substituted macrolide antibiotic, is tested against gram-positive and gram-negative bacteria.
性状
Solid
IC50 & Target[1][2]
Macrolide
体外研究(In Vitro)
Midecamycin inhibits the majority of streptococci, staphylococci, and strains of Haemophilus and Listeria at concentrations of less than 3.1 μg/mL. Midecamycin is a 16-membered macrolide. Midecamycin is a new macrolide antibiotic, which is produced by Streptomyces mycarofaciens.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature or refrigerated transport.
储存方式
Powder; -20°C; 3 years; 4°C; 2 years;
结构分类
AntibioticsMacro
来源
Streptomyces mycarofaciens
溶解度数据
体外研究:DMSO : ≥ 36 mg/mL(44.23 mM)*≥ means soluble, but saturation unknown. 配制储存液